⌘K

Home/Filings/4/0001209191-24-000463

4//SEC Filing

Sandoval Elisabeth 4

Accession 0001209191-24-000463

CIK 0001566044other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:14 PM ET

Size

5.8 KB

Accession

0001209191-24-000463

Insider Transaction Report

Form 4

Period: 2024-01-01

VYNE Therapeutics Inc.VYNE

Sandoval Elisabeth

Director

Transactions

Award
Stock Option (right to buy)
2024-01-01+20,000→ 20,000 total
Exercise: $2.33Exp: 2033-12-31→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1

filerCIK 0001632295

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 5:14 PM ET
Size: 5.8 KB

View on SEC.gov